Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India

Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexus platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexus. Doctors and researchers will be able to gain insights into the latest advancements in research and trials related to cancer.

Featured News

Die Arbeitsgemeinschaft Internistische Onkologie (AIO) und AMRIT entwickeln innovativen onkologischen Datenhub

Pressemitteilung vom 08.01.2025 Die Amrit AG, ein Unternehmen der Partex Gruppe - einem führenden Anbieter von KI-Lösungen im Gesundheitswesen - gibt heute de...

Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical forPartnership and Out-Licensing of AK0707

Partnership aims to expand therapeutic potential of proprietary autotaxin inhibitor through AI-driven approach Frankfurt, Germany – Date – Partex, a leader in ...

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3 rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce i...

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce its partnership wi...

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF Lifesciences, an established ...

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the results of a pilot project carr...

Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing

Frankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical giant Sanofi, ...

Innoplexus and AIO Studien gGmbH are jointly announcing the start of a pilot project as part of the AIO data hub initiative

January 02, 2024 - Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health data analysis, and AIO Studien gGmbH, ...

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV ...

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary medical exchange,...

More Press Releases

Die Arbeitsgemeinschaft Internistische Onkologie (AIO) und AMRIT entwickeln innovativen onkologischen Datenhub

Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical forPartnership and Out-Licensing of AK0707

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

...

What’s New in Ontosight® Terminal 1 . 1

Die Arbeitsgemeinschaft Internistische Onkologie (AIO) und AMRIT entwickeln innovativen onkologischen Datenhub

Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical forPartnership and Out-Licensing of AK0707

Innoplexus wins Horizon Interactive Gold Award for Curia App

Ontosight^® Terminal

FREE for a limited time

Try now

We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device.